OraSure receives funding to further COVID-19 test clearance

By: Stacy Wescoe
September 23, 2021 10:09 am

Just days after announcing that it had received a $205 million federal contract to provide COVID-19 InteliSwab tests, Bethlehem’s OraSure said the Biomedical Advanced Research Development Authority (BARDA) will provide up to $13.6 million in funding for the Company to obtain 510(k) clearance and CLIA waiver for their COVID-19 rapid test, InteliSwab, from the Food & Drug Administration.

Get Essential Business News

First time registering your paid subscription? Click here

Having trouble with login?
Please contact [email protected].

Writer Stacy Wescoe has her finger on the pulse of the business community in the Greater Lehigh Valley and keeps you up-to-date with technology and trends, plus what coworkers and competitors are talking about around the water cooler — and on social media. She can be reached at [email protected] or 610-807-9619, ext. 4104. Follow her on Twitter and on Facebook.